DTC healthcare brand Musely has secured $360 million in non-dilutive funding from General Catalyst, meaning the company did not give up equity. The capital will be used to aggressively expand customer acquisition efforts for its skin, hair, and menopause care products.
Background
Musely is a direct-to-consumer healthcare brand focused on dermatology and women's health, operating in the growing telehealth and personalized medicine space.
- Source
- TechCrunch
- Published
- May 2, 2026 at 06:39 AM
- Score
- 5.0 / 10